An arsenic oxoacid consisting of three hydroxy groups attached to a central arsenic atom.
Chemical ID:
MESH:C032793
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased secretion of IL1B protein]; [Arsenic Trioxide co-treated with Lipopolysaccharides] results in increased expression of IL1B protein; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased secretion of IL1B protein]; Arsenic Trioxide results in increased expression of and results in increased secretion of IL1B protein; boric acid inhibits the reaction [Arsenic Trioxide results in increased expression of IL1B mRNA]; boric acid inhibits the reaction [Arsenic Trioxide results in increased expression of IL1B protein]; Lenalidomide inhibits the reaction [[Arsenic Trioxide co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[Arsenic Trioxide co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]; NEAT1 mRNA affects the reaction [Arsenic Trioxide affects the expression of IL1B mRNA]; NEAT1 mRNA affects the reaction [Arsenic Trioxide affects the expression of IL1B protein]; polydatin inhibits the reaction [Arsenic Trioxide results in increased expression of IL1B mRNA]; pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased secretion of IL1B protein]; Taurine inhibits the reaction [[Arsenic Trioxide co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]; Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of IL1B protein]; trans-sodium crocetinate inhibits the reaction [Arsenic Trioxide results in increased expression of IL1B protein]
18alpha,20beta-hydroxy-11-oxo-norolean-12-en-3beta-yl-2-O-beta-D-glucopyranurosyl-alpha-D-glucopyranosiduronate magnesium tetrahydrate inhibits the reaction [Arsenic Trioxide results in increased expression of IL1B mRNA]; 18alpha,20beta-hydroxy-11-oxo-norolean-12-en-3beta-yl-2-O-beta-D-glucopyranurosyl-alpha-D-glucopyranosiduronate magnesium tetrahydrate inhibits the reaction [Arsenic Trioxide results in increased expression of IL1B protein]; 2-aminoethoxydiphenyl borate inhibits the reaction [Arsenic Trioxide results in decreased expression of IL1B mRNA]; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid inhibits the reaction [Arsenic Trioxide results in decreased expression of IL1B mRNA]; [Arsenic Trioxide results in increased abundance of arsenite] which results in increased expression of IL1B protein; Arsenic Trioxide inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IL1B protein]; Arsenic Trioxide inhibits the reaction [anthrax toxin results in increased secretion of and results in increased cleavage of IL1B protein]; Arsenic Trioxide inhibits the reaction [Nigericin results in increased cleavage of IL1B protein]; Arsenic Trioxide promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; ATF4 protein affects the reaction [Arsenic Trioxide results in decreased expression of IL1B mRNA]; Plant Extracts inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic Trioxide] which results in increased expression of IL1B protein]; Quin2 inhibits the reaction [Arsenic Trioxide results in decreased expression of IL1B mRNA]; Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of IL1B protein]
3-methyladenine inhibits the reaction [[Arsenic Trioxide co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of IL1B protein]; [acetyl-11-ketoboswellic acid co-treated with Arsenic Trioxide] results in decreased secretion of IL1B protein; [Arsenic Trioxide co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of IL1B protein; Arsenic Trioxide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IL1B protein]; Arsenic Trioxide promotes the reaction [Tretinoin results in increased expression of IL1B mRNA]; Arsenic Trioxide promotes the reaction [Tretinoin results in increased secretion of IL1B protein]; AS3MT mRNA promotes the reaction [Arsenic Trioxide results in increased expression of IL1B protein]; CA 074 methyl ester inhibits the reaction [[Arsenic Trioxide co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of IL1B protein]; IGF2BP2 protein promotes the reaction [Arsenic Trioxide results in increased secretion of IL1B protein]; METTL14 protein promotes the reaction [Arsenic Trioxide results in increased secretion of IL1B protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[Arsenic Trioxide co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of IL1B protein]; Taurine inhibits the reaction [[Arsenic Trioxide co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of IL1B protein]
